In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series C results in $30mm for Mako Surgical

Executive Summary

Mako Surgical (minimally invasive devices for knee surgery) raised $30mm in its Series C financing round led by Tudor Investment. New backer Ziegler Meditech Equity Partners was joined by returning shareholders Exxel Group, MDS Capital, Aperture Venture Partners, Ivy Healthcare Capital, and Sycamore Ventures. The company will use the proceeds to expand the presence of its Makoplasty product for knee osteoarthritis and to develop next-generation technologies and implants.
Deal Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies